DYN Dynegy Inc.

Dynegy Cancels Third Quarter 2017 Conference Call and Webcast

Dynegy Inc. (NYSE: DYN) today announced that following the Company’s October 30, 2017 announcement of its signed merger agreement with Vistra Energy, it will not be holding the conference call and webcast that was previously scheduled for Thursday, November 2. The Company will issue its third quarter 2017 results earnings release and related SEC filings as previously scheduled for Wednesday, November 1, 2017. Supplemental materials related to Dynegy’s third quarter earnings will be available via the Investor Relations section of Dynegy’s website at www.dynegy.com.

About Dynegy

Throughout the Northeast, Mid-Atlantic, Midwest, and Texas, Dynegy operates 27,000 megawatts (MW) of power generating facilities capable of producing enough energy to supply more than 22 million American homes. We generate power safely and responsibly for 1.2 million electricity customers who depend on that energy to grow and thrive.

EN
31/10/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Dynegy Inc.

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: July 26, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: July 19, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: July 15, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Dyne Therapeutics Inc: 1 director

A director at Dyne Therapeutics Inc bought 100,000 shares at 9.110USD and the significance rating of the trade was 99/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch